Enzo Biochem (ENZ) Revenue & Revenue Breakdown

OverviewOwnership Financials Chart

Enzo Biochem Revenue Highlights

Latest Revenue (Y)

$31.91M

Latest Revenue (Q)

$7.33M

Main Segment (Y)

Consolidated Member

Main Geography (Y)

UNITED STATES

Enzo Biochem Revenue by Period

Enzo Biochem Revenue by Year

Date	Revenue	Change
2024-07-31	$31.91M	2.72%
2023-07-31	$31.06M	-70.99%
2022-07-31	$107.07M	-9.05%
2021-07-31	$117.73M	54.87%
2020-07-31	$76.02M	-6.34%
2019-07-31	$81.17M	-22.48%
2018-07-31	$104.71M	-2.87%
2017-07-31	$107.80M	4.90%
2016-07-31	$102.77M	5.30%
2015-07-31	$97.60M	1.72%
2014-07-31	$95.95M	2.39%
2013-07-31	$93.71M	-9.10%
2012-07-31	$103.08M	1.03%
2011-07-31	$102.03M	5.10%
2010-07-31	$97.08M	8.38%
2009-07-31	$89.57M	15.14%
2008-07-31	$77.80M	47.04%
2007-07-31	$52.91M	32.85%
2006-07-31	$39.83M	-8.24%
2005-07-31	$43.40M	4.22%
2004-07-31	$41.64M	-21.08%
2003-07-31	$52.77M	-2.31%
2002-07-31	$54.02M	-7.52%
2001-07-31	$58.41M	16.75%
2000-07-31	$50.03M	12.93%
1999-07-31	$44.30M	9.65%
1998-07-31	$40.40M	15.76%
1997-07-31	$34.90M	1.16%
1996-07-31	$34.50M	8.83%
1995-07-31	$31.70M	39.04%
1994-07-31	$22.80M	14.00%
1993-07-31	$20.00M	-

Enzo Biochem generated $31.91M in revenue during NA 2024, up 2.72% compared to the previous quarter, and up 39.31% compared to the same period a year ago.

Enzo Biochem Revenue by Quarter

Date	Revenue	Change
2025-01-31	$7.33M	18.04%
2024-10-31	$6.21M	-17.45%
2024-07-31	$7.53M	-6.18%
2024-04-30	$8.02M	-6.21%
2024-01-31	$8.55M	9.57%
2023-10-31	$7.81M	-139.70%
2023-07-31	$-19.66M	-222.06%
2023-04-30	$16.11M	-1.41%
2023-01-31	$16.34M	-10.60%
2022-10-31	$18.28M	-9.90%
2022-07-31	$20.28M	-22.65%
2022-04-30	$26.22M	-22.98%
2022-01-31	$34.05M	28.38%
2021-10-31	$26.52M	6.88%
2021-07-31	$24.81M	-24.34%
2021-04-30	$32.80M	4.23%
2021-01-31	$31.47M	9.81%
2020-10-31	$28.66M	46.75%
2020-07-31	$19.53M	15.52%
2020-04-30	$16.90M	-12.80%
2020-01-31	$19.38M	-4.07%
2019-10-31	$20.21M	-3.41%
2019-07-31	$20.92M	6.40%
2019-04-30	$19.66M	1.73%
2019-01-31	$19.33M	-9.09%
2018-10-31	$21.26M	-13.06%
2018-07-31	$24.45M	-4.58%
2018-04-30	$25.63M	-4.91%
2018-01-31	$26.95M	-2.62%
2017-10-31	$27.68M	-1.76%
2017-07-31	$28.17M	4.00%
2017-04-30	$27.09M	3.16%
2017-01-31	$26.26M	-0.09%
2016-10-31	$26.28M	-1.20%
2016-07-31	$26.60M	0.64%
2016-04-30	$26.43M	7.63%
2016-01-31	$24.56M	-2.45%
2015-10-31	$25.18M	-2.02%
2015-07-31	$25.70M	7.13%
2015-04-30	$23.99M	3.87%
2015-01-31	$23.09M	-6.98%
2014-10-31	$24.82M	-0.33%
2014-07-31	$24.91M	3.87%
2014-04-30	$23.98M	4.58%
2014-01-31	$22.93M	-5.00%
2013-10-31	$24.13M	3.71%
2013-07-31	$23.27M	2.97%
2013-04-30	$22.60M	1.75%
2013-01-31	$22.21M	-13.34%
2012-10-31	$25.63M	-2.95%
2012-07-31	$26.41M	1.78%
2012-04-30	$25.95M	3.91%
2012-01-31	$24.97M	-3.03%
2011-10-31	$25.75M	-3.96%
2011-07-31	$26.82M	3.83%
2011-04-30	$25.83M	8.82%
2011-01-31	$23.73M	-7.48%
2010-10-31	$25.65M	2.83%
2010-07-31	$24.95M	4.86%
2010-04-30	$23.79M	2.60%
2010-01-31	$23.19M	-7.86%
2009-10-31	$25.16M	2.58%
2009-07-31	$24.53M	6.37%
2009-04-30	$23.06M	10.26%
2009-01-31	$20.92M	-0.70%
2008-10-31	$21.06M	-0.53%
2008-07-31	$21.18M	11.75%
2008-04-30	$18.95M	3.97%
2008-01-31	$18.23M	-

Enzo Biochem generated $7.33M in revenue during Q2 2025, up 18.04% compared to the previous quarter, and up 93.95% compared to the same period a year ago.

Enzo Biochem Revenue Breakdown

Enzo Biochem Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Jul 22	Jul 21	Jul 20	Jul 19	Jul 18
Consolidated Member	$107.07M	-	-	-	-
ClinicalLaboratoryServicesMember	-	$86.98M	-	-	-
LifeSciencesProductsMember	-	$30.75M	-	-	-
ConsolidatedMember	-	$117.73M	-	-	-
ClinicalServicesThreeMember	-	-	$5.98M	-	-
ClinicalServicesMember	-	-	$24.89M	-	-
ClinicalServicesTwoMember	-	-	$6.26M	-	-
ClinicalServices1Member	-	-	$10.82M	-	-
Clinical Labs	-	-	-	$51.12M	-
Consolidated	-	-	-	$81.17M	$104.71M
Life Sciences	-	-	-	$30.05M	$29.94M

Enzo Biochem's latest annual revenue breakdown by segment (product or service), as of Jul 22: Consolidated Member (100.00%).

Quarterly Revenue by Product

Product/Service	Jul 22	Apr 22	Jan 22	Oct 21	Jul 21	Apr 21	Jan 21	Oct 20	Apr 20	Jan 20	Oct 19	Jul 19	Apr 19	Jan 19	Oct 18	Jul 18	Apr 18
Consolidated Member	$20.28M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
ProductsMember	-	$7.59M	$10.37M	$6.78M	$7.78M	$7.48M	-	-	-	-	-	-	-	-	-	-	-
ClinicalServicesMember	-	$18.63M	$23.67M	$16.75M	$21.22M	$9.74M	-	-	-	-	-	-	-	-	-	-	-
ConsolidatedMember	-	$26.22M	$34.05M	$26.52M	$32.80M	$31.47M	-	-	-	-	-	-	-	-	-	-	-
ClinicalLabsMember	-	-	-	$19.74M	$25.02M	$23.99M	-	-	-	-	-	-	-	-	-	-	-
ClinicalServicesThreeMember	-	-	-	-	-	-	-	$1.87M	$1.13M	-	-	-	-	-	-	-	-
ClinicalServices1Member	-	-	-	-	-	-	-	$3.26M	$9.74M	-	-	-	-	-	-	-	-
ClinicalServicesTwoMember	-	-	-	-	-	-	-	$2.56M	$1.66M	-	-	-	-	-	-	-	-
Product Revenue	-	-	-	-	-	-	-	-	-	$6.87M	$7.43M	-	-	-	-	-	-
Consolidated	-	-	-	-	-	-	-	-	-	-	-	$20.92M	$19.66M	$19.33M	$21.26M	$24.45M	$25.63M
Life Sciences	-	-	-	-	-	-	-	-	-	-	-	$7.85M	$7.68M	$7.49M	-	-	-
Clinical Services	-	-	-	-	-	-	-	-	-	-	-	-	$11.75M	$12.00M	$14.30M	-	-
Products	-	-	-	-	-	-	-	-	-	-	-	-	$7.91M	$7.33M	$6.96M	-	-
Clinical Labs	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$16.78M	$18.14M

Enzo Biochem's latest quarterly revenue breakdown by segment (product or service), as of Jul 22: Consolidated Member (100.00%).

Enzo Biochem Revenue Breakdown by Country

Annual Revenue by Country

Country	Jul 24	Jul 23	Jul 22	Jul 21	Jul 20
Europe	$8.56M	$8.45M	$8.57M	$10.39M	-
Asia Pacific	$3.86M	$4.06M	$4.29M	$4.74M	-
UNITED STATES	$19.49M	$18.55M	$19.78M	$102.60M	-
Consolidated Member	-	-	$107.07M	-	-
European Union	-	-	-	-	$7.48M
RestofworldMember	-	-	-	-	$4.50M

Enzo Biochem's latest annual revenue breakdown by geography, as of Jul 24: UNITED STATES (61.08%), Europe (26.83%), and Asia Pacific (12.09%).

Quarterly Revenue by Country

Country	Apr 25	Jan 25	Oct 24	Jul 24	Apr 24	Jan 24	Oct 23	Jul 23	Apr 23	Jan 23	Oct 22	Jul 22	Jan 22	Oct 21	Jul 21	Apr 21	Jan 21	Oct 20	Apr 20
Europe	$1.71M	$1.71M	$1.66M	$1.78M	$2.36M	$2.29M	$2.14M	$2.58M	$1.69M	$2.28M	$1.90M	-	-	-	-	-	-	-	-
UNITED STATES	$4.05M	$4.83M	$3.76M	$4.89M	$4.79M	$5.17M	$4.63M	$5.27M	$5.04M	$4.14M	$4.09M	$6.75K	$3.86K	$3.46M	-	-	-	-	-
Asia Pacific	$642.00K	$792.00K	$785.00K	$854.00K	$870.00K	$1.10M	$1.03M	$1.11M	$754.00K	$1.09M	$1.10M	$1.22K	$908.00	$1.11M	$1.32M	-	-	-	-
Consolidated Member	-	-	-	-	-	-	-	-	-	-	-	$20.28M	-	-	-	-	-	-	-
European Union	-	-	-	-	-	-	-	-	-	-	-	-	$2.40K	$2.01K	$2.59M	$2.73M	$2.63M	$2.38M	$1.79M
RestofworldMember	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$1.17M	$1.17M

Enzo Biochem's latest quarterly revenue breakdown by geography, as of Apr 25: UNITED STATES (63.32%), Europe (26.65%), and Asia Pacific (10.03%).

Enzo Biochem Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
ME	23andMe	$219.64M	$25.42M
ENZ	Enzo Biochem	$31.91M	$7.33M
CSCI	COSCIENS Biopharma	$9.13M	$1.50M
ATON	AlphaTON Capital	-	-

ENZ Revenue FAQ

What is Enzo Biochem’s yearly revenue?

Enzo Biochem's yearly revenue for 2024 was $31.91M, representing an increase of 2.72% compared to 2023. The company's yearly revenue for 2023 was $31.06M, representing a decrease of -70.99% compared to 2022. ENZ's yearly revenue for 2022 was $107.07M, representing a decrease of -9.05% compared to 2021.

What is Enzo Biochem’s quarterly revenue?

Enzo Biochem's quarterly revenue for Q2 2025 was $7.33M, a 18.04% increase from the previous quarter (Q1 2025), and a -14.25% decrease year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $6.21M, a -17.45% decrease from the previous quarter (Q4 2024), and a -20.41% decrease year-over-year (Q1 2024). ENZ's quarterly revenue for Q4 2024 was $7.53M, a -6.18% decrease from the previous quarter (Q3 2024), and a 0% increase year-over-year (Q4 2023).

What is Enzo Biochem’s revenue growth rate?

Enzo Biochem's revenue growth rate for the last 3 years (2022-2024) was -70.20%, and for the last 5 years (2020-2024) was -58.03%.

What are Enzo Biochem’s revenue streams?

Enzo Biochem's revenue streams in l 22 are Consolidated Member

What is Enzo Biochem’s main source of revenue?

For the fiscal year ending Jul 22, the largest source of revenue of Enzo Biochem was Consolidated Member. This segment made a revenue of $107.07M, representing 100.00% of the company's total revenue.